Dr John R Brouillette, MD - Medicare Nephrology in Homewood, AL

Dr John R Brouillette, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Homewood, Alabama. He went to University Of Florida College Of Medicine and graduated in 1993 and has 31 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice Nephrology Associates, Pc and his current practice location is 35 W Lakeshore Dr, Homewood, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 226-5900.

Dr John R Brouillette is licensed to practice in Alabama (license number 18202) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1821056318.

Contact Information

Dr John R Brouillette, MD
35 W Lakeshore Dr,
Homewood, AL 35209-7253
(205) 226-5900
(205) 226-5937



Physician's Profile

Full NameDr John R Brouillette
GenderMale
SpecialityNephrology
Experience31 Years
Location35 W Lakeshore Dr, Homewood, Alabama
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr John R Brouillette attended and graduated from University Of Florida College Of Medicine in 1993
  NPI Data:
  • NPI Number: 1821056318
  • Provider Enumeration Date: 05/03/2006
  • Last Update Date: 10/31/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 6002000155
  • Enrollment ID: I20101102001025

Medical Identifiers

Medical identifiers for Dr John R Brouillette such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1821056318NPI-NPPES
000007964MedicaidAL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology 18202 (Alabama)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Fmc ForestdaleBirmingham, ALDialysis facility
Rcg OneontaOneonta, ALDialysis facility
Shelby Baptist Medical CenterAlabaster, ALHospital
Brookwood Baptist Medical CenterBirmingham, ALHospital
St Vincents BlountOneonta, ALHospital
St Vincent's BirminghamBirmingham, ALHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Nephrology Associates, Pc155733085928

News Archive

China Jo-Jo second quarter revenue increases 27.9% to $15.7 million

China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.

Florida's largest insurer enters Medicaid system; Texas may ask feds for block grant

In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.

Phase II study of OPAXIO to be revealed

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.

Leprosy still present in the U.S.

Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr John R Brouillette allows following entities to bill medicare on his behalf.
Entity NameNephrology Associates, Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023030152
PECOS PAC ID: 1557330859
Enrollment ID: O20041001000790

News Archive

China Jo-Jo second quarter revenue increases 27.9% to $15.7 million

China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.

Florida's largest insurer enters Medicaid system; Texas may ask feds for block grant

In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.

Phase II study of OPAXIO to be revealed

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.

Leprosy still present in the U.S.

Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States.

Read more Medical News

› Verified 9 days ago

Entity NameFresenius Vascular Care Birmingham Mso Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710766829
PECOS PAC ID: 9537419890
Enrollment ID: O20240220002651

News Archive

China Jo-Jo second quarter revenue increases 27.9% to $15.7 million

China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.

Florida's largest insurer enters Medicaid system; Texas may ask feds for block grant

In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.

Phase II study of OPAXIO to be revealed

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.

Leprosy still present in the U.S.

Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John R Brouillette is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr John R Brouillette, MD
35 W Lakeshore Dr,
Homewood, AL 35209-7253

Ph: (205) 226-5900
Dr John R Brouillette, MD
35 W Lakeshore Dr,
Homewood, AL 35209-7253

Ph: (205) 226-5900

News Archive

China Jo-Jo second quarter revenue increases 27.9% to $15.7 million

China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.

Florida's largest insurer enters Medicaid system; Texas may ask feds for block grant

In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.

Phase II study of OPAXIO to be revealed

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.

Leprosy still present in the U.S.

Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States.

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Homewood, AL

Dr. Jeffrey H Glaze, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 35 W Lakeshore Dr, Homewood, AL 35209
Phone: 205-226-5900    Fax: 205-226-5937
Emily Dolbare Feely, MD
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 2700 Rodgers Drive, Suite 102, Homewood, AL 35209
Phone: 205-226-5900    Fax: 205-226-5937
William Lyndon, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 35 W Lakeshore Dr, Homewood, AL 35209
Phone: 205-226-5900    Fax: 205-226-5937
Dr. Oksana Senyk, M.D., PH.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 2045 Brookwood Medical Ctr Dr Ste 1, Homewood, AL 35209
Phone: 205-978-0550    Fax: 205-978-0085
Agata Przekwas, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 35 W Lakeshore Dr, Homewood, AL 35209
Phone: 205-226-5900    Fax: 205-226-5937
Mitchel Scott Touger, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 300 Royal Tower Dr, Homewood, AL 35209
Phone: 205-874-1958    Fax: 205-874-1943
Joelle P Hamilton, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 3485 Independence Drive, Homewood, AL 35209
Phone: 205-930-0920    Fax: 205-445-0115

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.